Salvia officinalis extract in the treatment of patients with mild to moderate Alzheimer's disease: a double blind, randomized and placebo- controlle.. Acetylcholine esterase inhibitors are the only agents approved by the Food and Drug Administration for the treatment of Alzheimer's disease. All other agents prescribed for the treatment of Alzheimer's disease are used on an off- label basis. Current research into new drugs is focused on agents that will prevent, slow down and/or halt the progress of the disease process. Salvia officinalis has been used in herbal medicine for many centuries. Pros: Cons: Makes continuous sound for approximately 10-15 seconds after squeezed Easy for a blind dog to track Highly rated on Amazon, many dogs seem to love it! The American Foundation for the Blind (AFB) removes barriers, creates solutions, and expands possibilities so people with vision loss can achieve their full potential. News, discography, lyrics, and sound files. Tech news and expert opinion from The Telegraph's technology team. Read articles and watch video on the tech giants and innovative startups. Charity providing a range of information for blind or partially sighted people. Includes fund raising details and events. ![]() Blind ItemsIt has been suggested, on the basis of traditional medicine, its in vitro cholinergic binding properties and modulation of mood and cognitive performance in humans, that Salvia officinalis might potentially provide a novel natural treatment for Alzheimer's disease. The objective of this study was to assess the efficacy and safety of Salvia officinalis extract using a fixed dose (6. Alzheimer's disease, over a 4- month period. METHODS: This was a 4- month, parallel group, placebo- controlled trial undertaken in three centres in Tehran, Iran. Patients with mild to moderate Alzheimer's disease aged between 6. Alzheimer's Disease Assessment Scale (ADAS- cog) and < or = 2 on the Clinical Dementia Rating (CDR) were randomized to placebo or fixed dose of S. Over the 1. 6 weeks, the main efficacy measures were the change in the ADAS- cog and CDR- Sum of Boxes scores compared with baseline. In addition, side- effects were systematically recorded throughout the study using a checklist. RESULTS: At 4 months, S. There were no significant differences in the two groups in terms of observed side- effects except agitation that appears to be more frequent in the placebo group (P = 0. CONCLUSIONS: The results of this study indicate the efficacy of S.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. Archives
March 2018
Categories |